2 results match your criteria: "The Sixth Affiliated Hospital of Guangxi Medical University Yulin 537000[Affiliation]"
Can proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors regress coronary atherosclerotic plaque? A systematic review and meta-analysis.
Am J Transl Res
January 2023
Department of Cardiology, Yulin First People's Hospital, The Sixth Affiliated Hospital of Guangxi Medical University Yulin 537000, Guangxi, China.
Objective: Whether inhibition of proprotein convertase subtilisin/kexin type 9 (PCSK9) promotes the regression of coronary atherosclerotic plaque in statin-treated individuals remains unclear. This study examined whether PCSK9 inhibitors combined with statin therapy could increase atherosclerotic plaque regression compared with statin therapy alone.
Methods: PubMed, the Cochrane Central Register of Controlled Trials (CENTRAL), the database Clinical trials, and the Web of Science were searched to report the coronary atherosclerotic plaque of PCSK9 inhibitors using intravascular ultrasonography (IVUS) or optical coherence tomography (OCT) in statin patients.
Acute myocardial infarction with no chest pain following a Trimeresurus stejnegeri snakebite: a case report.
Am J Transl Res
June 2022
Department of Emergency Medicine, Yulin First People's Hospital (The Sixth Affiliated Hospital of Guangxi Medical University) Yulin 537000, Guangxi Zhuang Autonomous Region, China.
A 74-year-old female was bitten by a Trimeresurus stejnegeri, which is an unusual but dangerous type of snakebite. After the snakebite, the patient developed oedema, pain and numbness in the injured limb, and acute myocardial infarction, but no chest pain. The patient received base treatment, including anti-venom serum, statins and wound cleaning.
View Article and Find Full Text PDF